References
- Akanuma S, Uchida Y, Ohtsuki S, et al. (2011). Molecular-weight-dependent, anionic-substrate-preferential transport of β-lactam antibiotics via multidrug resistance-associated protein 4. Drug Metab Pharmacokinet 26:602–11
- Anderle P, Nielsen CU, Pinsonneault J, et al. (2006). Genetic variants of the human dipeptide transporter PEPT1. J Pharmacol Exp Ther 316:636–46
- Batard E, Lecadet N, Goffinet N, et al. (2015). High variability among Emergency Departments in 3rd-generation cephalosporins and fluoroquinolones use for community-acquired pneumonia. Infection 43:681–9
- Bishayee K, Khuda-Bukhsh AR, Huh SO. (2015). PLGA-loaded gold-nanoparticles precipitated with quercetin downregulate HDAC-Akt activities controlling proliferation and activate p53-ROS crosstalk to induce apoptosis in hepatocarcinoma cells. Mol Cells 38:518–27
- Boots AW, Haenen GR, Bast A. (2008). Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585:325–37
- Cascorbi I. (2006). Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol Ther 112:457–73
- Cermak R, Wein S, Wolffram S, Langguth P. (2009). Effects of the flavonol quercetin on the bioavailability of simvastatin in pigs. Eur J Pharm Sci 38:519–24
- D’Avolio A, Carcieri C, Cusato J, et al. (2014). Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms. J Antimicrob Chemother 69:3061–6
- Denny Joseph KM, Muralidhara. (2015). Combined oral supplementation of fish oil and quercetin enhances neuroprotection in a chronic rotenone rat model: relevance to Parkinson’s disease. Neurochem Res 40:894–905
- Diletti E, Hauschke D, Steinijans VW. (1991). Sample size determination for bioequivalence assessment by means of confidence intervals. Int J Clin Pharmacol Ther Toxicol 29:1–8
- Gormaz JG, Quintremil S, Rodrigo R. (2015). Cardiovascular disease: a target for the pharmacological effects of quercetin. Curr Top Med Chem 15:1735–42
- Heinz SA, Henson DA, Austin MD, et al. (2010). Quercetin supplementation and upper respiratory tract infection: a randomized community clinical trial. Pharmacol Res 62:237–42
- Ito K, Koresawa T, Nakano K, Horie T. (2004). Mrp2 is involved in benzylpenicillin-induced choleresis. Am J Physiol Gastrointest Liver Physiol 287:G42–9
- Kato Y, Takahara S, Kato S, et al. (2008). Involvement of multidrug resistance-associated protein 2 (Abcc2) in molecular weight-dependent biliary excretion of beta-lactam antibiotics. Drug Metab Dispos 36:1088–96
- Kennedy J. (2005). Herb and supplement use in the US adult population. Clin Ther 27:1847–58
- Liu Y, Wu YM, Zhang PY. (2015). Protective effects of curcumin and quercetin during benzo(a)pyrene induced lung carcinogenesis in mice. Eur Rev Med Pharmacol Sci 19:1736–43
- Nakakariya M, Shimada T, Irokawa M, et al. (2008). Identification and species similarity of OATP transporters responsible for hepatic uptake of beta-lactam antibiotics. Drug Metab Pharmacokinet 23:347–55
- Rizwan AN, Burckhardt G. (2007). Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles. Pharm Res 24:450–70
- Sathirakul K, Suzuki H, Yasuda K, et al. (1993). Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats. J Pharmacol Exp Ther 265:1301–12
- Tamai I, Nezu J, Uchino H, et al. (2000). Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun 273:251–60
- Tsai D, Jamal JA, Davis JS, et al. (2015). Interethnic differences in pharmacokinetics of antibacterials. Clin Pharmacokinet 54:243–60
- Tsuji A, Terasaki T, Tamai I, Takeda K. (1990). In vivo evidence for carrier-mediated uptake of beta-lactam antibiotics through organic anion transport systems in rat kidney and liver. J Pharmacol Exp Ther 253:315–20
- Uwai Y, Saito H, Inui K. (2002). Rat renal organic anion transporter rOAT1 mediates transport of urinary-excreted cephalosporins, but not of biliary-excreted cefoperazone. Drug Metab Pharmacokinet 17:125–9
- Wenzel U, Kuntz S, Diestel S, Daniel H. (2002). PEPT1-mediated cefixime uptake into human intestinal epithelial cells is increased by Ca2 + channel blockers. Antimicrob Agents Chemother 46:1375–80
- Wu CH, Wang CC, Kennedy J. (2013). The prevalence of herb and dietary supplement use among children and adolescents in the United States: results from the 2007 National Health Interview Survey. Complement Ther Med 21:358–63
- Wu LX, Guo CX, Chen WQ, et al. (2012). Inhibition of the organic anion-transporting polypeptide 1B1 by quercetin: an in vitro and in vivo assessment. Br J Clin Pharmacol 73:750–7
- Zhang EY, Fu DJ, Pak YA, et al. (2004). Genetic polymorphisms in human proton-dependent dipeptide transporter PEPT1: implications for the functional role of Pro586. J Pharmacol Exp Ther 310:437–45